Results 21 to 30 of about 2,648,667 (204)

ENLIGHT (European Network for Light Ion Hadron Therapy) and its role in Hadron therapy [PDF]

Health and Technology
Abstract Purpose This study provides a comprehensive overview of the progress in hadron therapy within Europe, particularly highlighting the critical roles of the Proton Ion Medical Machine Study (PIMMS) and the European Network for Light Ion Hadron Therapy (ENLIGHT). Methods
Georgieva, P, Dosanjh, M
openaire   +3 more sources

Shielding Studies for a Hadron Therapy Center

Nuclear Technology, 2009
The Ion Beam Applications Company is developing a compact superconducting cyclotron for hadron therapy. This C400 cyclotron will deliver 400 MeV per nucleon 12 C beams and will be installed in the Advanced Resource Center for Hadrontherapy in Europe in Caen, France. Shielding studies are based on the Particle and Heavy Ion Transport code System (PHITS)
Stichelbaut, Frederic, Canon, T., Jongen, Yves   +2 more
openaire   +3 more sources

ENLIGHT and other EU-funded projects in hadron therapy [PDF]

Br J Radiol, 2010
Following impressive results from early phase trials in Japan and Germany, there is a current expansion in European hadron therapy. This article summarises present European Union-funded projects for research and co-ordination of hadron therapy across ...
Jones, B, B Jones, R Meyer, Dosanjh, M, Meyer, R, M Dosanjh   +5 more
core   +3 more sources

Development and dosimetric verification of static SHArc: Step‐and‐shoot carbon ion arc therapy for LETd escalation in pancreatic tumors [PDF]

Medical Physics, Volume 52, Issue 10, October 2025.
Abstract Background Carbon ion radiotherapy (CIRT) offers higher linear energy transfer (LET) and superior relative biological effectiveness, making it a promising option for treating hypoxic, radioresistant tumors. Spot‐scanning Hadron Arc (SHArc) therapy enables dose‐averaged LET (LETd) escalation in the tumor but increases planning and setup ...
Filipa Baltazar, Thomas Tessonnier, Stewart Mein, Jakob Liermann, Abdallah Qubala, Jürgen Debus, Andrea Mairani   +6 more
wiley   +2 more sources

Suitability of Polyacrylamide-Based Dosimetric Gel for Proton and Carbon Ion Beam Geometric Characterization [PDF]

Gels
Experimental measurement of dose distributions is a pivotal step in the quality assurance of radiotherapy treatments, especially for those relying on high delivery accuracy such as hadron therapy.
Riccardo Brambilla, Luca Trombetta, Gabriele Magugliani, Stefania Russo, Alessia Bazani, Eleonora Rossi, Eros Mossini, Elena Macerata, Francesco Galluccio, Mario Mariani, Mario Ciocca   +10 more
doaj   +2 more sources

Hadron Therapy Machine Simulations Using BDSIM [PDF]

, 2018
Minimising the background radiation dose in hadron therapy from particle losses and secondary emissions is of the highest importance for patient protection. To achieve this, tracking particles from source to the patient delivery region in a single simulation provides a quantitative description that distinguishes the background radiation from the ...
Shields, W., Boogert, S.T., Nevay, L.J., Snuverink, J.   +3 more
openaire   +3 more sources

Advancing Proton Therapy: A Review of Geant4 Simulation for Enhanced Planning and Optimization in Hadron Therapy [PDF]

Journal of Medical Signals and Sensors
Proton therapy is a cancer treatment method that uses high-energy proton beams to target and destroy cancer cells. In recent years, the use of proton therapy in cancer treatment has increased due to its advantages over traditional radiation methods, such
Mahnaz Etehadtavakol, Parvaneh Shokrani, Ahmad Shanei   +2 more
doaj   +2 more sources

Out‐of‐field neutron radiation from clinical proton, helium, carbon, and oxygen ion beams [PDF]

Medical Physics, Volume 52, Issue 6, Page 4924-4940, June 2025.
Abstract Background In hadron therapy, out‐of‐field doses, which may in the long‐term cause secondary cancers, are mostly due to neutrons. Very recently, 4He and 16O beams have been added to protons and 12C ions for clinical therapy. Purpose The focus of this article is to compare secondary neutron doses produced by clinical protons, 4He, 12C, and 16O ...
Matteo Bolzonella, Marco Caresana, Andrea Cirillo, Josep M. Martí‐Climent, Evangelina Martínez‐Francés, Christina Mooshammer, Stefan Schmidt, Stephan Brons, Marco Silari, Christina Stengl, Liliana Stolarczyk, José Vedelago   +11 more
wiley   +2 more sources

Cancer epidemiology and patient recruitment for hadron therapy

Strahlentherapie und Onkologie, 1999
Patient recruitment is an important issue in the feasibility study of a hadron therapy programme such as Med-AUSTRON. Data on cancer incidence in Europe, Austria, and neighbouring countries are reviewed for the most frequent tumors suitable for charged particle therapy.
Engels, H, Wambersie, André
openaire   +4 more sources

Hadron Therapy Physics and Simulations [PDF]

, 2014
This brief provides an in-depth overview of the physics of hadron therapy, ranging from the history to the latest contributions to the subject. It covers the mechanisms of protons and carbon ions at the molecular level (DNA breaks and proteins 53BP1 and ...
d’Ávila Nunes, Marcos
openaire   +2 more sources